Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 24 | 2024 | 429 | 3.530 |
Why?
|
| Parents | 27 | 2024 | 1017 | 2.420 |
Why?
|
| Neoplasms | 31 | 2024 | 2751 | 2.050 |
Why?
|
| Truth Disclosure | 9 | 2020 | 103 | 1.630 |
Why?
|
| Medical Oncology | 6 | 2023 | 214 | 1.150 |
Why?
|
| Physician-Patient Relations | 6 | 2020 | 425 | 1.120 |
Why?
|
| Communication | 9 | 2023 | 508 | 1.030 |
Why?
|
| Chronic Disease | 8 | 2023 | 1168 | 1.020 |
Why?
|
| Terminally Ill | 4 | 2015 | 28 | 0.990 |
Why?
|
| Decision Making | 9 | 2019 | 649 | 0.890 |
Why?
|
| Physicians | 6 | 2020 | 583 | 0.820 |
Why?
|
| Trust | 2 | 2020 | 75 | 0.710 |
Why?
|
| Quality of Life | 13 | 2023 | 1918 | 0.660 |
Why?
|
| Benchmarking | 1 | 2019 | 131 | 0.620 |
Why?
|
| Stress, Psychological | 8 | 2024 | 555 | 0.610 |
Why?
|
| Emotions | 3 | 2019 | 364 | 0.600 |
Why?
|
| Child | 49 | 2024 | 24168 | 0.570 |
Why?
|
| Hospitals, Pediatric | 10 | 2020 | 779 | 0.530 |
Why?
|
| Surveys and Questionnaires | 17 | 2020 | 3641 | 0.510 |
Why?
|
| Prognosis | 14 | 2023 | 4498 | 0.450 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 272 | 0.390 |
Why?
|
| Child, Preschool | 32 | 2023 | 13858 | 0.360 |
Why?
|
| Nursing Staff, Hospital | 2 | 2011 | 60 | 0.350 |
Why?
|
| Male | 45 | 2024 | 59866 | 0.320 |
Why?
|
| Parent-Child Relations | 4 | 2019 | 246 | 0.320 |
Why?
|
| Female | 45 | 2024 | 65278 | 0.300 |
Why?
|
| Pediatrics | 2 | 2015 | 1142 | 0.300 |
Why?
|
| Hope | 3 | 2018 | 13 | 0.300 |
Why?
|
| Infant | 25 | 2023 | 12355 | 0.290 |
Why?
|
| Professional-Family Relations | 5 | 2017 | 95 | 0.290 |
Why?
|
| Adult | 25 | 2024 | 28926 | 0.290 |
Why?
|
| Humans | 56 | 2024 | 122853 | 0.290 |
Why?
|
| 3-Iodobenzylguanidine | 2 | 2004 | 12 | 0.280 |
Why?
|
| Adolescent | 29 | 2023 | 19037 | 0.280 |
Why?
|
| Self Report | 3 | 2018 | 502 | 0.280 |
Why?
|
| Infant, Newborn | 19 | 2021 | 8120 | 0.270 |
Why?
|
| Patient Preference | 2 | 2017 | 103 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 820 | 0.260 |
Why?
|
| Prospective Studies | 12 | 2021 | 5996 | 0.260 |
Why?
|
| Child Welfare | 2 | 2017 | 66 | 0.250 |
Why?
|
| Fatigue | 2 | 2018 | 218 | 0.250 |
Why?
|
| Social Support | 3 | 2018 | 343 | 0.250 |
Why?
|
| Pain | 4 | 2015 | 448 | 0.250 |
Why?
|
| Residence Characteristics | 1 | 2007 | 265 | 0.240 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 1290 | 0.240 |
Why?
|
| Poverty | 3 | 2024 | 416 | 0.230 |
Why?
|
| Attitude of Health Personnel | 3 | 2017 | 639 | 0.230 |
Why?
|
| Hospitals | 1 | 2007 | 397 | 0.230 |
Why?
|
| Income | 3 | 2024 | 133 | 0.230 |
Why?
|
| Terminal Care | 3 | 2015 | 114 | 0.220 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5017 | 0.220 |
Why?
|
| Symptom Assessment | 2 | 2021 | 96 | 0.210 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 157 | 0.210 |
Why?
|
| Middle Aged | 13 | 2020 | 25798 | 0.210 |
Why?
|
| Neuroblastoma | 2 | 2004 | 511 | 0.200 |
Why?
|
| Anxiety | 3 | 2024 | 952 | 0.200 |
Why?
|
| Caregivers | 2 | 2018 | 563 | 0.190 |
Why?
|
| United States | 8 | 2021 | 10538 | 0.170 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 1682 | 0.170 |
Why?
|
| Analgesics, Opioid | 2 | 2014 | 396 | 0.170 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 154 | 0.170 |
Why?
|
| Cohort Studies | 9 | 2023 | 4673 | 0.170 |
Why?
|
| Home Care Services | 2 | 2012 | 67 | 0.160 |
Why?
|
| Cranial Irradiation | 1 | 2019 | 69 | 0.160 |
Why?
|
| Patient Care Planning | 2 | 2023 | 122 | 0.160 |
Why?
|
| Philadelphia | 5 | 2017 | 21 | 0.160 |
Why?
|
| Family | 3 | 2021 | 572 | 0.160 |
Why?
|
| Workload | 1 | 2019 | 147 | 0.150 |
Why?
|
| Proton Therapy | 1 | 2019 | 120 | 0.150 |
Why?
|
| Depression | 2 | 2024 | 1216 | 0.150 |
Why?
|
| Patient Care | 1 | 2018 | 100 | 0.140 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3319 | 0.140 |
Why?
|
| Health Communication | 1 | 2017 | 26 | 0.140 |
Why?
|
| Attitude to Death | 2 | 2007 | 38 | 0.140 |
Why?
|
| Access to Information | 1 | 2017 | 39 | 0.140 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2015 | 63 | 0.130 |
Why?
|
| Hospitalization | 3 | 2014 | 1731 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 283 | 0.130 |
Why?
|
| Problem Solving | 2 | 2013 | 64 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2018 | 256 | 0.130 |
Why?
|
| Medulloblastoma | 1 | 2019 | 338 | 0.130 |
Why?
|
| Survivors | 1 | 2018 | 346 | 0.130 |
Why?
|
| Irritable Mood | 1 | 2015 | 8 | 0.120 |
Why?
|
| Carboplatin | 1 | 2015 | 78 | 0.120 |
Why?
|
| Family Health | 1 | 2015 | 258 | 0.120 |
Why?
|
| Siblings | 1 | 2015 | 193 | 0.120 |
Why?
|
| Prevalence | 5 | 2024 | 2384 | 0.120 |
Why?
|
| Advance Care Planning | 1 | 2015 | 38 | 0.120 |
Why?
|
| Antiemetics | 1 | 2014 | 23 | 0.120 |
Why?
|
| Conscious Sedation | 1 | 2014 | 62 | 0.120 |
Why?
|
| Drug Hypersensitivity | 1 | 2015 | 96 | 0.120 |
Why?
|
| Logistic Models | 2 | 2016 | 1777 | 0.120 |
Why?
|
| Senna Extract | 1 | 2013 | 1 | 0.110 |
Why?
|
| Nausea | 1 | 2014 | 98 | 0.110 |
Why?
|
| Iodine Radioisotopes | 2 | 2004 | 75 | 0.110 |
Why?
|
| Cathartics | 1 | 2013 | 26 | 0.110 |
Why?
|
| Goals | 1 | 2014 | 127 | 0.110 |
Why?
|
| Child Behavior | 1 | 2015 | 230 | 0.110 |
Why?
|
| Young Adult | 9 | 2021 | 8826 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 134 | 0.110 |
Why?
|
| Vomiting | 1 | 2014 | 116 | 0.110 |
Why?
|
| Judgment | 1 | 2013 | 35 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 193 | 0.100 |
Why?
|
| Constipation | 1 | 2013 | 113 | 0.100 |
Why?
|
| Fathers | 1 | 2013 | 66 | 0.100 |
Why?
|
| Hospice Care | 1 | 2012 | 30 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 223 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2015 | 364 | 0.100 |
Why?
|
| Acute Disease | 1 | 2015 | 1092 | 0.100 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 311 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2014 | 391 | 0.090 |
Why?
|
| Bereavement | 1 | 2011 | 19 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 39 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 710 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2015 | 677 | 0.090 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2014 | 470 | 0.090 |
Why?
|
| Glioma | 1 | 2015 | 497 | 0.090 |
Why?
|
| Medical Audit | 1 | 2011 | 100 | 0.090 |
Why?
|
| Complementary Therapies | 1 | 2011 | 42 | 0.090 |
Why?
|
| Disease Progression | 4 | 2018 | 1996 | 0.090 |
Why?
|
| Mothers | 1 | 2013 | 348 | 0.090 |
Why?
|
| Health Personnel | 1 | 2014 | 500 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 588 | 0.080 |
Why?
|
| Salvage Therapy | 1 | 2011 | 193 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2015 | 15927 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 532 | 0.080 |
Why?
|
| Critical Illness | 1 | 2013 | 594 | 0.080 |
Why?
|
| Spirituality | 1 | 2007 | 47 | 0.070 |
Why?
|
| Community-Institutional Relations | 1 | 2007 | 30 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2014 | 697 | 0.070 |
Why?
|
| Nurse-Patient Relations | 1 | 2007 | 16 | 0.070 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2018 | 163 | 0.070 |
Why?
|
| Boston | 2 | 2017 | 110 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 171 | 0.070 |
Why?
|
| Data Collection | 1 | 2007 | 383 | 0.060 |
Why?
|
| WAGR Syndrome | 1 | 2003 | 7 | 0.060 |
Why?
|
| Housing | 1 | 2024 | 60 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2015 | 12070 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2003 | 333 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 1998 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2015 | 459 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2015 | 1378 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1033 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 1222 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 59 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 14 | 0.040 |
Why?
|
| Psychology, Child | 1 | 2019 | 45 | 0.040 |
Why?
|
| Cancer Pain | 1 | 2018 | 24 | 0.040 |
Why?
|
| Parental Notification | 1 | 2017 | 2 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2018 | 77 | 0.040 |
Why?
|
| Technology | 1 | 2018 | 65 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2018 | 60 | 0.040 |
Why?
|
| Oncologists | 1 | 2017 | 29 | 0.040 |
Why?
|
| Social Class | 1 | 2018 | 181 | 0.040 |
Why?
|
| Risk Factors | 3 | 2018 | 9928 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 581 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 242 | 0.030 |
Why?
|
| Child Health | 1 | 2017 | 53 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 297 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2018 | 217 | 0.030 |
Why?
|
| Desensitization, Psychologic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Histamine H1 Antagonists | 1 | 2015 | 12 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 33 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2015 | 30 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 49 | 0.030 |
Why?
|
| Parenting | 1 | 2019 | 324 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2015 | 102 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2015 | 49 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 18917 | 0.030 |
Why?
|
| Vincristine | 1 | 2015 | 208 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 267 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2014 | 49 | 0.030 |
Why?
|
| Comprehension | 1 | 2014 | 73 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2014 | 35 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 666 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1235 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 473 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 676 | 0.030 |
Why?
|
| Aphorisms and Proverbs as Topic | 1 | 2013 | 1 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 316 | 0.030 |
Why?
|
| Patient Care Team | 2 | 2007 | 545 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 160 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2013 | 90 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2013 | 97 | 0.030 |
Why?
|
| Nursing, Private Duty | 1 | 2012 | 1 | 0.030 |
Why?
|
| Durable Medical Equipment | 1 | 2012 | 4 | 0.030 |
Why?
|
| Telemedicine | 1 | 2018 | 421 | 0.030 |
Why?
|
| Health Surveys | 1 | 2013 | 236 | 0.020 |
Why?
|
| Polyneuropathies | 1 | 2012 | 24 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 754 | 0.020 |
Why?
|
| Life Support Care | 1 | 2012 | 45 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 131 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1242 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 658 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1246 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 683 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2012 | 135 | 0.020 |
Why?
|
| Huntington Disease | 1 | 2012 | 141 | 0.020 |
Why?
|
| Religion | 1 | 2011 | 49 | 0.020 |
Why?
|
| Nurses | 1 | 2011 | 62 | 0.020 |
Why?
|
| Thinking | 1 | 2010 | 34 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 861 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 338 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 1000 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1407 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 251 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2014 | 510 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1581 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 3316 | 0.020 |
Why?
|
| Sibling Relations | 1 | 2007 | 13 | 0.020 |
Why?
|
| Expressed Emotion | 1 | 2007 | 9 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 57 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2007 | 134 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 1229 | 0.020 |
Why?
|
| Pain Management | 1 | 2007 | 167 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 397 | 0.020 |
Why?
|
| Chronology as Topic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 152 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2004 | 131 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 382 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 403 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 1005 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 654 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 1300 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 1473 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2022 | 0.010 |
Why?
|